SLOC1A2, FCGR3A and C1QA, selected by our approach as gene candidates for RA, are also targets of medications for RA such as Etanercept, Hydrocortisone and Ibuprofen. The gene discussed is FCGR3A; the disease is rheumatoid arthritis.